Bentham Science Logo

Track Your Manuscript:


CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 19, 10 Issues, 2020
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

CNS & Neurological Disorders - Drug Targets , Volume 8 - Number 6



Signal Transduction via Cannabinoid Receptors

, 8(6): 422 - 431

George D. Dalton, Caroline E. Bass, Cynthia G. Van Horn and Allyn C. Howlett


DOI: 10.2174/187152709789824615


Cannabinoids and Parkinsons Disease

, 8(6): 432 - 439

Moises Garcia-Arencibia, Concepcion Garcia and Javier Fernandez-Ruiz


DOI: 10.2174/187152709789824642







Mitochondria as a Therapeutic Target in Alzheimers Disease and Diabetes

, 8(6): 492 - 511

Paula I. Moreira, Sandra M. Cardoso, Claudia M. Pereira, Maria S. Santos and Catarina R. Oliveira


DOI: 10.2174/187152709789824651




Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)

Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Scopus CiteScore Metrics: 2.72

Advertisement

How to write and publish your papers in high impact journalsOctober Health DaysCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog